LZTS2 Antikörper
-
- Target Alle LZTS2 Antikörper anzeigen
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LZTS2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- leucine zipper, putative tumor suppressor 2
- Isotyp
- IgG
- Top Product
- Discover our top product LZTS2 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:2000, IHC: 1:20-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
- Andere Bezeichnung
- LZTS2 (LZTS2 Produkte)
- Hintergrund
- Synonyms:KIAA1813, LAPSER1 Background:Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin.
- Molekulargewicht
- 70-80 kDa
- Gen-ID
- 84445
- UniProt
- Q9BRK4
-